Table 2 shows the significant associations between high ECT2 expression in lung cancer and gender (P = 0.002), new tumor event (P = 0.026), pathologic T stage (P = 0.002), and therapeutic outcome (P = 0.012). This evidence concerns the gene ECT2 and neoplasm.